Abstract:ObjectivesTo investigate the methodology and clinical application of ultrasound attenuation imaging (ATI) and comparative analyze the diagnostic performance of ATI and controlled attenuation parameters (CAP) for detecting and grading hepatic steatosis. MethodsA total of 159 patients with NAFLD were prospectively enrolled. CAP and ATI examinations were performed within a week before proton magnetic resonance spectroscopy (H-1-MRS). Ten liver attenuation coefficient (AC) measurements by ATI were obtained in each patient. The interclass correlation coefficients (ICCs) of the intraobserver consistencies and the ICCs between the median of the first two through the first nine measurements and all 10 measurements were calculated. The correlations between H-1-MRS, CAP, biological data, and ATI were evaluated. The significant factors associated with ATI and the diagnostic performance of ATI and CAP for detecting hepatic steatosis was evaluated. ResultsThe median value of AC for detecting hepatic steatosis was 0.831 dB/cm/MHz. For the intraobserver consistency of ATI, the ICC was 0.931. Compared with 10 measurements, a minimum of four ATI measurements was required. The correlation of AC with hepatic fat fraction (HFF) was significantly higher than that of CAP (0.603 vs 0.326, P = .0015). The HFF and triglyceride (TG) were the significant factors for the ATI. The area under the receiver operating characteristics (ROC) curves of ATI and CAP were 0.939 and 0.788 for detecting >= 10% hepatic steatosis; 0.751 and 0.572 for detecting >33% hepatic steatosis. The cutoff values of ATI and CAP were 0.697 dB/cm/MHz and 310 dB/m for detecting >= 10% hepatic steatosis; 0.793 dB/cm/MHz and 328 dB/m for detecting >33% hepatic steatosis. The sensitivity of ATI and CAP were 85.92% and 52.11% for detecting >= 10% hepatic steatosis; 87.50% and 82.14% for detecting >33% hepatic steatosis. The specificity of ATI and CAP were 94.12% and 100% for detecting >= 10% hepatic steatosis; 54.37% and 43.69% for detecting >33% hepatic steatosis. ConclusionsATI technology showed excellent intraobserver consistency and the optimal minimum number of ATI measurements was 4. ATI is a promising noninvasive, quantitative and convenient tool for assessing hepatic steatosis.

Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective study

A Prospective Comparison of Three Ultrasound-Based Techniques in Quantitative Diagnosis of Hepatic Steatosis in NAFLD.

Controlled Attenuation Parameter by VCTE for Steatosis Assessment in Health Check Public with Reference to MRI-PDFF.

Controlled attenuation parameter for steatosis assessment in health checkup groups

A Comparative Study of Ultrasound Attenuation Imaging, Controlled Attenuation Parameters, and Magnetic Resonance Spectroscopy for the Detection of Hepatic Steatosis.

Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients

Quantitative Evaluation of Hepatic Steatosis Using Novel Ultrasound Technology Normalized Local Variance (NLV) and Its Standard Deviation with Different ROIs in Patients with Metabolic-Associated Fatty Liver Disease: a Pilot Study.

Correlation and Performance of three Ultrasound Techniques to Stage Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

A Comparison of Hepatic Steatosis Index, Controlled Attenuation Parameter and Ultrasound As Noninvasive Diagnostic Tools for Steatosis in Chronic Hepatitis B.

A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease

A new visual quantitative assessment of ultrasound attenuation parameters for the mild liver steatosis

Controlled Attenuation Parameter for Non-Invasive Assessment of Hepatic Steatosis in Chinese Patients

Analysis of Liver Steatosis Analysis and Controlled Attenuation Parameter for Grading Liver Steatosis in Patients with Chronic Hepatitis B.

Methodology exploration and reproducibility evaluation of TAI and TSI for quantitative ultrasound assessment of hepatic steatosis

An experimental study of quantitative diagnosis of fatty liver by imaging technology

The Diagnostic Value of Novel Ultrasound Attenuation Analysis in Detecting Liver Steatosis Identified by the Controlled Attenuation Parameter: a Diagnostic Accuracy Study

A comparative study of hepatic steatosis using two different qualitative ultrasound techniques measured based on magnetic resonance imaging‐derived proton density fat fraction

Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study

Diagnostic Accuracy of Controlled Attenuation Parameter (CAP) As a Non-Invasive Test for Steatosis in Suspected Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Influential factors and clinical value of controlled attenuation parameters in the evaluation of hepatic steatosis using FibroScan?

Prospective comparative diagnostic performance of quantitative ultrasound parameters for the measurement of hepatic steatosis in a biopsy-proven MASLD cohort